CBT for Medication-Resistant Psychosis

Most of the study connecting CBT (cognitive behavioral therapy) to psychosis, that fails to respond positively to medication, focuses on treating schizophrenia. It was necessary to address the hole in data regarding patients with medication-resistant psychosis treated with CBT on an outpatient basis. A meta-analysis was conducted investigating the CBT effectiveness after therapy concluded. The sources used for the meta-analysis were sixteen published articles outlining 12 randomized controlled trials. A total 552 of 639 subjects completed the trials with a vast majority experiencing positive effects from CBT at post-treatment. Later, when examined in follow-up visits, the effects remained consistent. In all, CBT has been found to offer more positive benefit than medication alone.

Read the full article here: CBT for Medication-Resistant Psychosis: A Meta-analytic Review | Beck Institute Blog